cangrelor (Q3655338)

Cangrelor (English)

19 November 2016

CSCCNC1=NC(=NC2=C1N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F

1 reference

Cangrelor (English)

19 November 2016

CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F

1 reference

parenteral route of administration

Cangrelor (English)

19 November 2016

50 milligram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=B01AC25

active ingredient in

Kengrexal

1 reference

European Medicines Agency product number

EMEA/H/C/003773

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003773/human_med_001852.jsp

22 March 2017

1 reference

14 February 2018

World Health Organisation international non-proprietary name

cangrelor (English)

1 reference

cangrelor (English)

significant drug interaction

3 October 2016

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

fondaparinux

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

G protein-coupled receptor 17

subject has role

antagonist

1 reference

Purinergic receptor P2Y12

17 August 2016

subject has role

antagonist

1 reference

Purinergic receptor P2Y13

17 August 2016

subject has role

antagonist

1 reference

imported from Wikimedia project

17 August 2016

pregnancy category

US pregnancy category C

1 reference

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Cangrelor

last update

3 October 2017

mass

774.948313 dalton

1 reference

platelet aggregation inhibitors

Cangrelor (English)

3 October 2016

1 reference

Medical Subject Headings

MeSH descriptor ID

C117446

purinergic P2Y receptor antagonists

15 March 2018

1 reference

InChI=1S/C17H25Cl2F3N5O12P3S2/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32)/t8-,10-,11-,14-/m1/s1

Medical Subject Headings

15 March 2018

Cangrelor

0 references

Identifiers

InChI

1 reference

Cangrelor (English)

19 November 2016

2 references

Cangrelor (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

163706-06-7

2 references

cangrelor (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=163706-06-7

9 April 2021

1 reference

Cangrelor (English)

19 November 2016

2 references

Cangrelor (English)

19 November 2016

Reaxys registry number

8303713

1 reference

cangrelor (English)

3 October 2016

mapping relation type

2 references

cangrelor (English)

3 October 2016

International Chemical Identifier

InChI

InChI=1S/C17H25Cl2F3N5O12P3S2/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32)/t8-,10-,11-,14-/m1/s1

1 reference

CANGRELOR (English)

19 November 2016

1 reference

Hazardous Substances Data Bank

1 reference

1 reference

28 October 2019

Cangrelor (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

Cangrelor (English)

publication date

17 November 2015

1 reference

cangrelor (English)

19 November 2016

1 reference

Medical Subject Headings

14 March 2018

1 reference

cangrelor (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0240386

2 references

based on heuristic

inferred from InChIKey

2 references

cangrelor (English)

19 November 2016

NDF-RT ID

N0000191733

1 reference

cangrelor (English)

19 November 2016

0 references

1 reference

1 reference

Microsoft Academic ID (discontinued)

cangrelor (English)

3 October 2016

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

archive URL

https://web.archive.org/web/20220125070108/https://docs.openalex.org/download-snapshot/snapshot-data-format

25 January 2022

1 reference